Baseline Study Sample Clauses

Baseline Study. The Recipient shall carry out a baseline study of the Project’s outcome indicators agreed with the Association, including an assessment of the socio-economic status of the target populations using said indicators, and shall prepare and furnish to the Association, not later than twelve (12) months after the Effective Date, a report integrating the results of said baseline study.
Sample 1Sample 2
AutoNDA by SimpleDocs
Baseline Study. 8.3.1 A desk-based study was undertaken and a review of previous investigation reports was also included to locate previously identified resources and also to update previous impact assessments and mitigation recommendations.
Sample 1
Baseline Study. TechnoServe will initiate the baseline study once USDA has approved the Evaluation Plan. TechnoServe hopes to be able to schedule the baseline study to be undertaken between November 15 and January 31st, 2015 by an external and specialized evaluation firm. TechnoServe will select the firm on a competitive basis, and will ensure that the selected firm complies with the following requirements:  Is financially and legally separate from the participant's organization;  Has staff with demonstrated knowledge, analytical capability, language skills and experience in conducting evaluations of development programs in African agriculture and agribusiness;  Uses acceptable analytical frameworks and methods to assess results, involving stakeholders and applying statistical analyses;  Uses local consultants, as appropriate, to conduct data collection and portions of the baseline studies; and,  Provides a detailed plan for the baseline study, major tasks and specific schedules prior to initiating the studies. TechnoServe will ensure that the evaluating firm has complete access to all relevant internal and external project documents, key correspondence with OCBD staff, and any other relevant project information that may facilitate the transparent and robust execution of the baseline study. The baseline study will help TechnoServe and OCBD staff optimize the initial allocation of project funding to achieve CIAP results and will be consistent with the following ROM criteria: Independence, Utility, Transparency, Relevance, Partnerships, Credibility, Rigor and Timeliness. The purpose of the baseline study is to:  Establish benchmarks against which CIAP’s progress on each of the project outcomes can be tracked, and  Inform decision-making about early project implementation planning and execution. 1The number of surveys will be sufficient to achieve a 95% confidence level as determined by the variance discovered during quantitative surveys during the baseline assessment. The variance of population determines the number of surveys required in order to achieve statistical significance.  Refine metrics: TechnoServe will coordinate with CIAP and M&E staff to finalize the proposed revised indicators and targets, with a set of compelling, defensible and credible metrics that are practical and relevant in indicating progress toward key outcomes. A final PMP will be submitted to USDA within 90 days of award, and all indicators and indicator targets will be finalized by Month 5...
Sample 1
Baseline Study. During this phase, a baseline study will be conducted. The consultant will be expected to actively participate in this baseline study. Risk analysis: Risks analysis will be conducted by the consultant. Identify risk covering contextual, but also operational and reputation risks. Each risk should be measured by estimating its probability and impact. Develop mitigation measures and actions for each of the risks. Writing/internal feedback/Exchanges: During writing, there will be a lot of exchanges within the formulation team, and with H/Q, UGA experts, Embassy and partners. During this phase the formulation team will define: • Outcome level indicators for the specific objectives defined in the country strategy; • The interventions that will be implemented; • For each intervention, a results framework showing the associated specific objectives and the expected results and their output level indicators shall be elaborated; • The duration of the interventions which may not exceed the duration of the country portfolio; • The actors that will partially or completely execute interventions, with indication of the contracting form, the conditions for sub-delegation and their management costs; • The execution modalities; • The target groups; • The budget envelope, broken down by specific objective, by intervention, by expected result and by contracting form, with an overview of the general means; • The expertise that Xxxxxx needs to execute the country portfolio. In summary this assignment consists of the following: Literature review; stakeholders’ consultations, studies/analysis and substantial contribution to the drafting of the both Country Strategy and the portfolio. Please note that the formulation of the global partnership opportunities will follow a similar methodology taking into the specific requirements of the third-party donor.
Sample 1
Baseline Study. Xxxxx and Xxxx hereby agree that a Pre- Acquisition Review assessment report of the Property by Xxxxx, if made, shall establish the true and correct condition of the Property as of the Effective Date and such assessment report shall be used as the only environmental, safety or other baseline study in the event a dispute arises after Closing concerning the condition of the Property, unless Aera gives notice to Xxxxx within thirty (30) days after its receipt of the Pre-Acquisition Review assessment report that it is contesting the results of or the conclusions reached in such assessment report in which case such Pre-Acquisition Review assessment report shall not be deemed the sole baseline study. Aera shall have the right, but not the obligation, at any time to conduct its own assessment of the Property. If prior to Closing, Aera determines, either from its own assessment, Xxxxx'x assessment or otherwise, that an adverse environmental condition may exist on any portion of the Property, then Aera may, in its sole discretion, either (i) remove the affected portion of the Property from the Property being conveyed and agree with Xxxxx to an adjusted Purchase Price or (ii) terminate this Agreement by giving notice of such termination to Xxxxx in writing prior to Closing. The rights and obligations of the Parties after such notice is given shall be as specified in the next sentence. If Aera and Xxxxx cannot agree on the proper adjustment to the Purchase Price, either Party may give written notice to the other Party prior to Closing to terminate this Agreement and upon the giving of such notice, neither Party shall have any further rights or obligations hereunder except for Xxxxx'x obligations and Xxxx's rights under the Confidentiality Agreement and the Indemnification Agreement. In the event both Aera and Xxxxx elect not to conduct Pre-Acquisition Review assessment reports, both Parties agree that the Phase I Environmental Site Assessment report dated October 27, 1998, prepared by Xxxxxxx/Xxxxx Consultants for Mobil Business Resources Corporation shall serve as the baseline study for purposes of this subsection.
Sample 1
Baseline Study. Buyer and Noble hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "PRE-ACQUISITION ENVIRONMENTAL ASSESSMENT") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Noble shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1
Baseline Study. Buyer and Shell hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "Pre-Acquisition Environmental Assessment") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Shell shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1
AutoNDA by SimpleDocs
Baseline Study. Buyer and Aera hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "PRE-ACQUISITION ENVIRONMENTAL ASSESSMENT") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Aera shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1
Baseline Study. 1.1 A baseline study shall be conducted:
Sample 1

Related to Baseline Study

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Feasibility Study Buyer will, at Buyer's expense and within ____ days from Effective Date ("Feasibility Study Period"), determine whether the Property is suitable, in Buyer's sole and absolute discretion, for ___________________ use. During the Feasibility Study Period, Buyer may conduct a Phase I environmental assessment and any other tests, analyses, surveys and investigations ("Inspections") that Buyer deems necessary to determine to Buyer's satisfaction the Property's engineering, architectural and environmental properties; zoning and zoning restrictions; subdivision statutes; soil and grade; availability of access public roads, water, and other utilities; consistency with local, state and regional growth management plans, availability of permits, government approvals, and licenses; and other inspections that Buyer deems appropriate to determine the Property's suitability for the Buyer's intended use. If the Property must be rezoned, Buyer will obtain the rezoning from the appropriatx xxxernment agencies. Seller will sign all documents Buyer is required to file in connection with development or rezoning approvals. Seller gives Buyer, its agents, contractors and assigns, the right to enter the Property at any time during the Feasibility Study Period for the purpose of conducting inspections; provided, however, that Buyer, its agents, contractors and assigns enter the Property and conduct inspections at their own risk. Buyer will indemnify and hold Seller harmless from xxxxes, damages, costs, claims and expenses of any nature, including attorney's fees, expenses and liability incurred in application for rezoning or related proceedings, and from liability to any person, arising from the conduct of any and all inspections of any work authorized by Buyer. Buyer will not engage in any activity that xxxxx result in a construction lien being filed against the Property without Seller's prior written consent. If this transaction does not close, Buyer will, at Buyer's expense, (1) repair all damages to the Property resulting from the Inspections and return the Property to the condition it was in prior to conduct of the Inspections, and (2) release to Seller all reports and other work generated as a result of the Inspections. Buyer will deliver written notice to Seller prior to the expiration of the Feasibility Study Period of Buyer's determination of whether or not the Properxx xx acceptable. Buyer's failure to comply with this notice requirement will constitute acceptance of the Property as suitable for Buyer's intended use in its "as is" condition. If the Property is unacceptable to Buyer and written notice of this fact is timely delivered to Seller, this Contract will be deemed terminated as of the day after the Feasibility Study period ends and Buyer's deposit(s) will be returned after Escrow Axxxx receives proper authorization form all interested parties.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Project Scope The physical scope of the Project shall be limited to only those capital improvements as described in Appendix A of this Agreement. In the event that circumstances require a change in such physical scope, the change must be approved by the District Committee, recorded in the District Committee's official meeting minutes, and provided to the OPWC Director for the execution of an amendment to this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.